Next Tuesday, December 11, 2018, TRIUMF will open its doors for a Public Open House and discussion related to the Institute for Advanced Medical Isotopes (IAMI).
TRIUMF research scientist Dr. Ania Kwiatkowski has been awarded the inaugural 2018 Stuart Jay Freedman Award of the American Physical Society (APS).
TRIUMF welcomed Prime Minister Trudeau for a special visit where he announced investments to support a new state-of-the art life sciences facility, the Institute for Advanced Medical Isotopes (IAMI)
Designed to maximize impact, build on existing strengths, and capitalize on emerging opportunities, TRIUMF’s Five-Year Plan 2020-2025 lays out a vision for Canada’s particle accelerator centre for the next five years and the decades beyond
Neutrino physics researchers at TRIUMF and around the world welcome new signals of support for planned Hyper-K detector
Vancouver photographer’s striking image selected from thousands of images submitted by hundreds of amateur and professional photographers around the world
Leading Canadian laboratories collaborate to produce Actinium-225, a rare medical isotope with the potential to revolutionize the fight against untreatable forms of cancer
A new short documentary, The Rarest Drug on Earth, is delving into the possibility for TRIUMF to take up the reins as the world’s largest producer of actinium-225.
With a Mitacs award win under his belt, TRIUMF graduate student, Vanier scholar, and UBC Ph.D. candidate Sébastien Rettie is embarking for the Weizmann Institute of Science to work on upgrades for ATLAS' New Muon Small Wheels system.
With help from TRIUMF scientists, the ALPHA experiment at CERN has for the first time observed a benchmark atomic energy transition in antihydrogen